Ligand · 3EL
3EL · N-{4-[(3-{2-[(trans-4-aminocyclohexyl)amino]pyrimidin-4-yl}pyridin-2-yl)oxy]naphthalen-1-yl}benzenesulfonamide
3EL, N-{4-[(3-{2-[(trans-4-aminocyclohexyl)amino]pyrimidin-4-yl}pyridin-2-yl)oxy]naphthalen-1-yl}benzenesulfonamide (C31 H30 N6 O3 S, 566.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 3EL
- Formula
- C31 H30 N6 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
3EL in 2 structures; the first of them:
- 4U79 · Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor. · 3EL A501 · binds ILE70, VAL78, ALA91, LYS93, LEU95, ARG107, GLU111, MET115 and 15 more
- 4U79 · Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor. · 3EL A501 · binds ILE70, VAL78, ALA91, LYS93, LEU95, ARG107, GLU111, MET115 and 15 more
Residues it binds most
LEU 2, MET 2, VAL 2, ALA 2, ASP 2, GLU 2, ILE 2, ARG 2, ASN 2, GLN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.